nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Transient ischaemic attack—Galantamine—Alzheimer's disease	0.0166	0.0175	CcSEcCtD
Nafarelin—Neurosis—Memantine—Alzheimer's disease	0.0149	0.0158	CcSEcCtD
Nafarelin—Neurosis—Rivastigmine—Alzheimer's disease	0.0146	0.0154	CcSEcCtD
Nafarelin—Libido increased—Galantamine—Alzheimer's disease	0.0138	0.0145	CcSEcCtD
Nafarelin—Transient ischaemic attack—Donepezil—Alzheimer's disease	0.0129	0.0136	CcSEcCtD
Nafarelin—Transient ischaemic attack—Memantine—Alzheimer's disease	0.0117	0.0123	CcSEcCtD
Nafarelin—Transient ischaemic attack—Rivastigmine—Alzheimer's disease	0.0114	0.0121	CcSEcCtD
Nafarelin—Hirsutism—Donepezil—Alzheimer's disease	0.0112	0.0118	CcSEcCtD
Nafarelin—Libido increased—Donepezil—Alzheimer's disease	0.0107	0.0113	CcSEcCtD
Nafarelin—Deep vein thrombosis—Donepezil—Alzheimer's disease	0.0107	0.0113	CcSEcCtD
Nafarelin—Libido increased—Memantine—Alzheimer's disease	0.00969	0.0102	CcSEcCtD
Nafarelin—Deep vein thrombosis—Memantine—Alzheimer's disease	0.00969	0.0102	CcSEcCtD
Nafarelin—Libido increased—Rivastigmine—Alzheimer's disease	0.00948	0.01	CcSEcCtD
Nafarelin—Menstrual disorder—Memantine—Alzheimer's disease	0.00865	0.00914	CcSEcCtD
Nafarelin—Pentagastrin—BCHE—Alzheimer's disease	0.00864	0.61	CrCbGaD
Nafarelin—Seborrhoeic dermatitis—Rivastigmine—Alzheimer's disease	0.00846	0.00894	CcSEcCtD
Nafarelin—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00818	0.00864	CcSEcCtD
Nafarelin—Cystitis—Galantamine—Alzheimer's disease	0.00809	0.00855	CcSEcCtD
Nafarelin—Urinary incontinence—Galantamine—Alzheimer's disease	0.00809	0.00855	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Memantine—Alzheimer's disease	0.00796	0.00841	CcSEcCtD
Nafarelin—Vaginal haemorrhage—Rivastigmine—Alzheimer's disease	0.00779	0.00823	CcSEcCtD
Nafarelin—Bladder pain—Galantamine—Alzheimer's disease	0.00757	0.008	CcSEcCtD
Nafarelin—Pleural effusion—Rivastigmine—Alzheimer's disease	0.00753	0.00795	CcSEcCtD
Nafarelin—Breast pain—Rivastigmine—Alzheimer's disease	0.00661	0.00698	CcSEcCtD
Nafarelin—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00634	0.0067	CcSEcCtD
Nafarelin—Cystitis—Donepezil—Alzheimer's disease	0.00627	0.00662	CcSEcCtD
Nafarelin—Urinary incontinence—Donepezil—Alzheimer's disease	0.00627	0.00662	CcSEcCtD
Nafarelin—Oliguria—Rivastigmine—Alzheimer's disease	0.00626	0.00661	CcSEcCtD
Nafarelin—Herpes simplex—Rivastigmine—Alzheimer's disease	0.00626	0.00661	CcSEcCtD
Nafarelin—Cerebrovascular accident—Galantamine—Alzheimer's disease	0.00621	0.00656	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00603	0.00637	CcSEcCtD
Nafarelin—Coordination abnormal—Memantine—Alzheimer's disease	0.006	0.00634	CcSEcCtD
Nafarelin—Pulmonary embolism—Memantine—Alzheimer's disease	0.00589	0.00623	CcSEcCtD
Nafarelin—Coordination abnormal—Rivastigmine—Alzheimer's disease	0.00587	0.0062	CcSEcCtD
Nafarelin—Bladder pain—Donepezil—Alzheimer's disease	0.00587	0.0062	CcSEcCtD
Nafarelin—Pulmonary embolism—Rivastigmine—Alzheimer's disease	0.00577	0.00609	CcSEcCtD
Nafarelin—Cystitis noninfective—Memantine—Alzheimer's disease	0.00576	0.00608	CcSEcCtD
Nafarelin—Urinary incontinence—Memantine—Alzheimer's disease	0.00569	0.00601	CcSEcCtD
Nafarelin—Cystitis—Memantine—Alzheimer's disease	0.00569	0.00601	CcSEcCtD
Nafarelin—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.00563	0.00595	CcSEcCtD
Nafarelin—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.00557	0.00588	CcSEcCtD
Nafarelin—Cystitis—Rivastigmine—Alzheimer's disease	0.00557	0.00588	CcSEcCtD
Nafarelin—Ear pain—Donepezil—Alzheimer's disease	0.00552	0.00584	CcSEcCtD
Nafarelin—Gastritis—Galantamine—Alzheimer's disease	0.00538	0.00569	CcSEcCtD
Nafarelin—Muscular weakness—Galantamine—Alzheimer's disease	0.00536	0.00567	CcSEcCtD
Nafarelin—Neoplasm—Memantine—Alzheimer's disease	0.00533	0.00563	CcSEcCtD
Nafarelin—Bladder pain—Memantine—Alzheimer's disease	0.00533	0.00563	CcSEcCtD
Nafarelin—Rash maculo-papular—Rivastigmine—Alzheimer's disease	0.00524	0.00554	CcSEcCtD
Nafarelin—Bladder pain—Rivastigmine—Alzheimer's disease	0.00521	0.00551	CcSEcCtD
Nafarelin—Neoplasm—Rivastigmine—Alzheimer's disease	0.00521	0.00551	CcSEcCtD
Nafarelin—Libido decreased—Donepezil—Alzheimer's disease	0.00508	0.00537	CcSEcCtD
Nafarelin—Hot flush—Donepezil—Alzheimer's disease	0.00504	0.00532	CcSEcCtD
Nafarelin—Increased appetite—Donepezil—Alzheimer's disease	0.00502	0.0053	CcSEcCtD
Nafarelin—Ear pain—Memantine—Alzheimer's disease	0.00502	0.0053	CcSEcCtD
Nafarelin—Menopausal symptoms—Donepezil—Alzheimer's disease	0.00499	0.00528	CcSEcCtD
Nafarelin—Ear pain—Rivastigmine—Alzheimer's disease	0.00491	0.00518	CcSEcCtD
Nafarelin—Hepatic function abnormal—Memantine—Alzheimer's disease	0.0049	0.00517	CcSEcCtD
Nafarelin—Cerebrovascular accident—Donepezil—Alzheimer's disease	0.00481	0.00508	CcSEcCtD
Nafarelin—Weight decreased—Galantamine—Alzheimer's disease	0.00475	0.00502	CcSEcCtD
Nafarelin—Eye pain—Memantine—Alzheimer's disease	0.00474	0.00501	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00468	0.00494	CcSEcCtD
Nafarelin—Depression—Galantamine—Alzheimer's disease	0.00467	0.00494	CcSEcCtD
Nafarelin—Affect lability—Donepezil—Alzheimer's disease	0.00464	0.0049	CcSEcCtD
Nafarelin—Eye pain—Rivastigmine—Alzheimer's disease	0.00464	0.0049	CcSEcCtD
Nafarelin—Libido decreased—Memantine—Alzheimer's disease	0.00461	0.00487	CcSEcCtD
Nafarelin—Hot flush—Memantine—Alzheimer's disease	0.00457	0.00483	CcSEcCtD
Nafarelin—Increased appetite—Memantine—Alzheimer's disease	0.00455	0.00481	CcSEcCtD
Nafarelin—Menopausal symptoms—Memantine—Alzheimer's disease	0.00453	0.00479	CcSEcCtD
Nafarelin—Libido decreased—Rivastigmine—Alzheimer's disease	0.00451	0.00477	CcSEcCtD
Nafarelin—Hot flush—Rivastigmine—Alzheimer's disease	0.00447	0.00473	CcSEcCtD
Nafarelin—Mood swings—Donepezil—Alzheimer's disease	0.00446	0.00472	CcSEcCtD
Nafarelin—Increased appetite—Rivastigmine—Alzheimer's disease	0.00446	0.00471	CcSEcCtD
Nafarelin—Menopausal symptoms—Rivastigmine—Alzheimer's disease	0.00444	0.00469	CcSEcCtD
Nafarelin—Epistaxis—Galantamine—Alzheimer's disease	0.00442	0.00467	CcSEcCtD
Nafarelin—Cerebrovascular accident—Memantine—Alzheimer's disease	0.00437	0.00461	CcSEcCtD
Nafarelin—Dry skin—Donepezil—Alzheimer's disease	0.00432	0.00456	CcSEcCtD
Nafarelin—Cerebrovascular accident—Rivastigmine—Alzheimer's disease	0.00427	0.00451	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00424	0.00448	CcSEcCtD
Nafarelin—Rhinitis—Galantamine—Alzheimer's disease	0.00422	0.00446	CcSEcCtD
Nafarelin—Affect lability—Memantine—Alzheimer's disease	0.00421	0.00445	CcSEcCtD
Nafarelin—Gastritis—Donepezil—Alzheimer's disease	0.00417	0.00441	CcSEcCtD
Nafarelin—Muscular weakness—Donepezil—Alzheimer's disease	0.00416	0.00439	CcSEcCtD
Nafarelin—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00415	0.00439	CcSEcCtD
Nafarelin—Affect lability—Rivastigmine—Alzheimer's disease	0.00412	0.00435	CcSEcCtD
Nafarelin—Abdominal distension—Donepezil—Alzheimer's disease	0.0041	0.00433	CcSEcCtD
Nafarelin—Mood swings—Memantine—Alzheimer's disease	0.00405	0.00428	CcSEcCtD
Nafarelin—Sweating increased—Donepezil—Alzheimer's disease	0.00397	0.00419	CcSEcCtD
Nafarelin—Mood swings—Rivastigmine—Alzheimer's disease	0.00397	0.00419	CcSEcCtD
Nafarelin—Dry skin—Memantine—Alzheimer's disease	0.00392	0.00414	CcSEcCtD
Nafarelin—Dry skin—Rivastigmine—Alzheimer's disease	0.00384	0.00405	CcSEcCtD
Nafarelin—Dysuria—Donepezil—Alzheimer's disease	0.00381	0.00402	CcSEcCtD
Nafarelin—Gastritis—Memantine—Alzheimer's disease	0.00379	0.004	CcSEcCtD
Nafarelin—Muscular weakness—Memantine—Alzheimer's disease	0.00377	0.00399	CcSEcCtD
Nafarelin—Weight increased—Donepezil—Alzheimer's disease	0.00371	0.00392	CcSEcCtD
Nafarelin—Gastritis—Rivastigmine—Alzheimer's disease	0.0037	0.00391	CcSEcCtD
Nafarelin—Muscular weakness—Rivastigmine—Alzheimer's disease	0.00369	0.0039	CcSEcCtD
Nafarelin—Mental disorder—Galantamine—Alzheimer's disease	0.00369	0.00389	CcSEcCtD
Nafarelin—Weight decreased—Donepezil—Alzheimer's disease	0.00368	0.00389	CcSEcCtD
Nafarelin—Malnutrition—Galantamine—Alzheimer's disease	0.00366	0.00387	CcSEcCtD
Nafarelin—Depression—Donepezil—Alzheimer's disease	0.00362	0.00383	CcSEcCtD
Nafarelin—Sweating increased—Memantine—Alzheimer's disease	0.0036	0.00381	CcSEcCtD
Nafarelin—Tension—Galantamine—Alzheimer's disease	0.00359	0.0038	CcSEcCtD
Nafarelin—Dysgeusia—Galantamine—Alzheimer's disease	0.00359	0.00379	CcSEcCtD
Nafarelin—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.00358	0.00378	CcSEcCtD
Nafarelin—Myocardial infarction—Donepezil—Alzheimer's disease	0.00356	0.00376	CcSEcCtD
Nafarelin—Nervousness—Galantamine—Alzheimer's disease	0.00356	0.00376	CcSEcCtD
Nafarelin—Conjunctivitis—Donepezil—Alzheimer's disease	0.00353	0.00373	CcSEcCtD
Nafarelin—Sweating increased—Rivastigmine—Alzheimer's disease	0.00352	0.00372	CcSEcCtD
Nafarelin—Desmopressin—PTGS1—Alzheimer's disease	0.00352	0.248	CrCbGaD
Nafarelin—Dysuria—Memantine—Alzheimer's disease	0.00346	0.00365	CcSEcCtD
Nafarelin—Epistaxis—Donepezil—Alzheimer's disease	0.00343	0.00362	CcSEcCtD
Nafarelin—Dysuria—Rivastigmine—Alzheimer's disease	0.00338	0.00357	CcSEcCtD
Nafarelin—Weight increased—Memantine—Alzheimer's disease	0.00337	0.00356	CcSEcCtD
Nafarelin—Weight decreased—Memantine—Alzheimer's disease	0.00335	0.00353	CcSEcCtD
Nafarelin—Weight increased—Rivastigmine—Alzheimer's disease	0.00329	0.00348	CcSEcCtD
Nafarelin—Vertigo—Galantamine—Alzheimer's disease	0.00329	0.00348	CcSEcCtD
Nafarelin—Depression—Memantine—Alzheimer's disease	0.00329	0.00347	CcSEcCtD
Nafarelin—Weight decreased—Rivastigmine—Alzheimer's disease	0.00327	0.00346	CcSEcCtD
Nafarelin—Rhinitis—Donepezil—Alzheimer's disease	0.00327	0.00345	CcSEcCtD
Nafarelin—Acute coronary syndrome—Memantine—Alzheimer's disease	0.00325	0.00343	CcSEcCtD
Nafarelin—Palpitations—Galantamine—Alzheimer's disease	0.00324	0.00342	CcSEcCtD
Nafarelin—Myocardial infarction—Memantine—Alzheimer's disease	0.00323	0.00341	CcSEcCtD
Nafarelin—Depression—Rivastigmine—Alzheimer's disease	0.00322	0.0034	CcSEcCtD
Nafarelin—Conjunctivitis—Memantine—Alzheimer's disease	0.00321	0.00339	CcSEcCtD
Nafarelin—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.00318	0.00336	CcSEcCtD
Nafarelin—Convulsion—Galantamine—Alzheimer's disease	0.00317	0.00335	CcSEcCtD
Nafarelin—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.00316	0.00334	CcSEcCtD
Nafarelin—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.00314	0.00331	CcSEcCtD
Nafarelin—Arthralgia—Galantamine—Alzheimer's disease	0.00312	0.00329	CcSEcCtD
Nafarelin—Chest pain—Galantamine—Alzheimer's disease	0.00312	0.00329	CcSEcCtD
Nafarelin—Myalgia—Galantamine—Alzheimer's disease	0.00312	0.00329	CcSEcCtD
Nafarelin—Epistaxis—Memantine—Alzheimer's disease	0.00311	0.00329	CcSEcCtD
Nafarelin—Sinusitis—Memantine—Alzheimer's disease	0.00309	0.00327	CcSEcCtD
Nafarelin—Epistaxis—Rivastigmine—Alzheimer's disease	0.00304	0.00321	CcSEcCtD
Nafarelin—Sinusitis—Rivastigmine—Alzheimer's disease	0.00303	0.0032	CcSEcCtD
Nafarelin—Rhinitis—Memantine—Alzheimer's disease	0.00297	0.00314	CcSEcCtD
Nafarelin—Shock—Galantamine—Alzheimer's disease	0.00294	0.00311	CcSEcCtD
Nafarelin—Rhinitis—Rivastigmine—Alzheimer's disease	0.0029	0.00307	CcSEcCtD
Nafarelin—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00289	0.00305	CcSEcCtD
Nafarelin—Alopecia—Donepezil—Alzheimer's disease	0.00288	0.00304	CcSEcCtD
Nafarelin—Mental disorder—Donepezil—Alzheimer's disease	0.00286	0.00302	CcSEcCtD
Nafarelin—Anorexia—Galantamine—Alzheimer's disease	0.00285	0.00301	CcSEcCtD
Nafarelin—Malnutrition—Donepezil—Alzheimer's disease	0.00284	0.003	CcSEcCtD
Nafarelin—Tension—Donepezil—Alzheimer's disease	0.00278	0.00294	CcSEcCtD
Nafarelin—Dysgeusia—Donepezil—Alzheimer's disease	0.00278	0.00294	CcSEcCtD
Nafarelin—Nervousness—Donepezil—Alzheimer's disease	0.00276	0.00291	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00272	0.00288	CcSEcCtD
Nafarelin—Insomnia—Galantamine—Alzheimer's disease	0.0027	0.00286	CcSEcCtD
Nafarelin—Paraesthesia—Galantamine—Alzheimer's disease	0.00268	0.00284	CcSEcCtD
Nafarelin—Alopecia—Memantine—Alzheimer's disease	0.00262	0.00276	CcSEcCtD
Nafarelin—Decreased appetite—Galantamine—Alzheimer's disease	0.0026	0.00274	CcSEcCtD
Nafarelin—Mental disorder—Memantine—Alzheimer's disease	0.00259	0.00274	CcSEcCtD
Nafarelin—Malnutrition—Memantine—Alzheimer's disease	0.00258	0.00272	CcSEcCtD
Nafarelin—Alopecia—Rivastigmine—Alzheimer's disease	0.00256	0.0027	CcSEcCtD
Nafarelin—Constipation—Galantamine—Alzheimer's disease	0.00256	0.0027	CcSEcCtD
Nafarelin—Vertigo—Donepezil—Alzheimer's disease	0.00255	0.00269	CcSEcCtD
Nafarelin—Mental disorder—Rivastigmine—Alzheimer's disease	0.00254	0.00268	CcSEcCtD
Nafarelin—Tension—Memantine—Alzheimer's disease	0.00253	0.00267	CcSEcCtD
Nafarelin—Dysgeusia—Memantine—Alzheimer's disease	0.00252	0.00267	CcSEcCtD
Nafarelin—Malnutrition—Rivastigmine—Alzheimer's disease	0.00252	0.00266	CcSEcCtD
Nafarelin—Nervousness—Memantine—Alzheimer's disease	0.0025	0.00264	CcSEcCtD
Nafarelin—Tension—Rivastigmine—Alzheimer's disease	0.00247	0.00261	CcSEcCtD
Nafarelin—Dysgeusia—Rivastigmine—Alzheimer's disease	0.00247	0.00261	CcSEcCtD
Nafarelin—Convulsion—Donepezil—Alzheimer's disease	0.00246	0.0026	CcSEcCtD
Nafarelin—Nervousness—Rivastigmine—Alzheimer's disease	0.00245	0.00259	CcSEcCtD
Nafarelin—Arthralgia—Donepezil—Alzheimer's disease	0.00242	0.00255	CcSEcCtD
Nafarelin—Chest pain—Donepezil—Alzheimer's disease	0.00242	0.00255	CcSEcCtD
Nafarelin—Myalgia—Donepezil—Alzheimer's disease	0.00242	0.00255	CcSEcCtD
Nafarelin—Oedema—Donepezil—Alzheimer's disease	0.00232	0.00245	CcSEcCtD
Nafarelin—Vertigo—Memantine—Alzheimer's disease	0.00232	0.00245	CcSEcCtD
Nafarelin—Shock—Donepezil—Alzheimer's disease	0.00228	0.00241	CcSEcCtD
Nafarelin—Palpitations—Memantine—Alzheimer's disease	0.00228	0.00241	CcSEcCtD
Nafarelin—Vertigo—Rivastigmine—Alzheimer's disease	0.00226	0.00239	CcSEcCtD
Nafarelin—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00224	0.00237	CcSEcCtD
Nafarelin—Convulsion—Memantine—Alzheimer's disease	0.00223	0.00236	CcSEcCtD
Nafarelin—Palpitations—Rivastigmine—Alzheimer's disease	0.00223	0.00235	CcSEcCtD
Nafarelin—Anorexia—Donepezil—Alzheimer's disease	0.00221	0.00233	CcSEcCtD
Nafarelin—Myalgia—Memantine—Alzheimer's disease	0.00219	0.00232	CcSEcCtD
Nafarelin—Chest pain—Memantine—Alzheimer's disease	0.00219	0.00232	CcSEcCtD
Nafarelin—Arthralgia—Memantine—Alzheimer's disease	0.00219	0.00232	CcSEcCtD
Nafarelin—Convulsion—Rivastigmine—Alzheimer's disease	0.00218	0.00231	CcSEcCtD
Nafarelin—Chest pain—Rivastigmine—Alzheimer's disease	0.00215	0.00227	CcSEcCtD
Nafarelin—Myalgia—Rivastigmine—Alzheimer's disease	0.00215	0.00227	CcSEcCtD
Nafarelin—Arthralgia—Rivastigmine—Alzheimer's disease	0.00215	0.00227	CcSEcCtD
Nafarelin—Asthenia—Galantamine—Alzheimer's disease	0.00214	0.00227	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00211	0.00223	CcSEcCtD
Nafarelin—Oedema—Memantine—Alzheimer's disease	0.0021	0.00222	CcSEcCtD
Nafarelin—Insomnia—Donepezil—Alzheimer's disease	0.00209	0.00221	CcSEcCtD
Nafarelin—Paraesthesia—Donepezil—Alzheimer's disease	0.00208	0.0022	CcSEcCtD
Nafarelin—Shock—Memantine—Alzheimer's disease	0.00207	0.00219	CcSEcCtD
Nafarelin—Dyspnoea—Donepezil—Alzheimer's disease	0.00206	0.00218	CcSEcCtD
Nafarelin—Oedema—Rivastigmine—Alzheimer's disease	0.00206	0.00217	CcSEcCtD
Nafarelin—Diarrhoea—Galantamine—Alzheimer's disease	0.00204	0.00216	CcSEcCtD
Nafarelin—Hyperhidrosis—Memantine—Alzheimer's disease	0.00203	0.00215	CcSEcCtD
Nafarelin—Shock—Rivastigmine—Alzheimer's disease	0.00202	0.00214	CcSEcCtD
Nafarelin—Decreased appetite—Donepezil—Alzheimer's disease	0.00201	0.00213	CcSEcCtD
Nafarelin—Desmopressin—PTGS2—Alzheimer's disease	0.00201	0.142	CrCbGaD
Nafarelin—Anorexia—Memantine—Alzheimer's disease	0.002	0.00212	CcSEcCtD
Nafarelin—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00199	0.0021	CcSEcCtD
Nafarelin—Constipation—Donepezil—Alzheimer's disease	0.00198	0.00209	CcSEcCtD
Nafarelin—Dizziness—Galantamine—Alzheimer's disease	0.00198	0.00209	CcSEcCtD
Nafarelin—Anorexia—Rivastigmine—Alzheimer's disease	0.00196	0.00207	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.00192	0.00202	CcSEcCtD
Nafarelin—Insomnia—Memantine—Alzheimer's disease	0.0019	0.00201	CcSEcCtD
Nafarelin—Vomiting—Galantamine—Alzheimer's disease	0.0019	0.00201	CcSEcCtD
Nafarelin—Paraesthesia—Memantine—Alzheimer's disease	0.00189	0.00199	CcSEcCtD
Nafarelin—Rash—Galantamine—Alzheimer's disease	0.00188	0.00199	CcSEcCtD
Nafarelin—Dermatitis—Galantamine—Alzheimer's disease	0.00188	0.00199	CcSEcCtD
Nafarelin—Dyspnoea—Memantine—Alzheimer's disease	0.00187	0.00198	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00187	0.00198	CcSEcCtD
Nafarelin—Headache—Galantamine—Alzheimer's disease	0.00187	0.00198	CcSEcCtD
Nafarelin—Insomnia—Rivastigmine—Alzheimer's disease	0.00186	0.00197	CcSEcCtD
Nafarelin—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00185	0.00195	CcSEcCtD
Nafarelin—Urticaria—Donepezil—Alzheimer's disease	0.00184	0.00194	CcSEcCtD
Nafarelin—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00183	0.00194	CcSEcCtD
Nafarelin—Decreased appetite—Memantine—Alzheimer's disease	0.00183	0.00193	CcSEcCtD
Nafarelin—Constipation—Memantine—Alzheimer's disease	0.0018	0.0019	CcSEcCtD
Nafarelin—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00179	0.00189	CcSEcCtD
Nafarelin—Nausea—Galantamine—Alzheimer's disease	0.00178	0.00188	CcSEcCtD
Nafarelin—Constipation—Rivastigmine—Alzheimer's disease	0.00176	0.00186	CcSEcCtD
Nafarelin—Urticaria—Memantine—Alzheimer's disease	0.00167	0.00176	CcSEcCtD
Nafarelin—Asthenia—Donepezil—Alzheimer's disease	0.00166	0.00176	CcSEcCtD
Nafarelin—Pruritus—Donepezil—Alzheimer's disease	0.00164	0.00173	CcSEcCtD
Nafarelin—Urticaria—Rivastigmine—Alzheimer's disease	0.00163	0.00173	CcSEcCtD
Nafarelin—Diarrhoea—Donepezil—Alzheimer's disease	0.00158	0.00167	CcSEcCtD
Nafarelin—Dizziness—Donepezil—Alzheimer's disease	0.00153	0.00162	CcSEcCtD
Nafarelin—Asthenia—Memantine—Alzheimer's disease	0.00151	0.00159	CcSEcCtD
Nafarelin—Pruritus—Memantine—Alzheimer's disease	0.00149	0.00157	CcSEcCtD
Nafarelin—Asthenia—Rivastigmine—Alzheimer's disease	0.00148	0.00156	CcSEcCtD
Nafarelin—Vomiting—Donepezil—Alzheimer's disease	0.00147	0.00156	CcSEcCtD
Nafarelin—Rash—Donepezil—Alzheimer's disease	0.00146	0.00154	CcSEcCtD
Nafarelin—Dermatitis—Donepezil—Alzheimer's disease	0.00146	0.00154	CcSEcCtD
Nafarelin—Pruritus—Rivastigmine—Alzheimer's disease	0.00146	0.00154	CcSEcCtD
Nafarelin—Headache—Donepezil—Alzheimer's disease	0.00145	0.00153	CcSEcCtD
Nafarelin—Diarrhoea—Memantine—Alzheimer's disease	0.00144	0.00152	CcSEcCtD
Nafarelin—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00141	0.00149	CcSEcCtD
Nafarelin—Dizziness—Memantine—Alzheimer's disease	0.00139	0.00147	CcSEcCtD
Nafarelin—Nausea—Donepezil—Alzheimer's disease	0.00138	0.00145	CcSEcCtD
Nafarelin—Dizziness—Rivastigmine—Alzheimer's disease	0.00136	0.00144	CcSEcCtD
Nafarelin—Vomiting—Memantine—Alzheimer's disease	0.00134	0.00141	CcSEcCtD
Nafarelin—Rash—Memantine—Alzheimer's disease	0.00133	0.0014	CcSEcCtD
Nafarelin—Dermatitis—Memantine—Alzheimer's disease	0.00132	0.0014	CcSEcCtD
Nafarelin—Headache—Memantine—Alzheimer's disease	0.00132	0.00139	CcSEcCtD
Nafarelin—Vomiting—Rivastigmine—Alzheimer's disease	0.00131	0.00138	CcSEcCtD
Nafarelin—Rash—Rivastigmine—Alzheimer's disease	0.0013	0.00137	CcSEcCtD
Nafarelin—Dermatitis—Rivastigmine—Alzheimer's disease	0.0013	0.00137	CcSEcCtD
Nafarelin—Headache—Rivastigmine—Alzheimer's disease	0.00129	0.00136	CcSEcCtD
Nafarelin—Nausea—Memantine—Alzheimer's disease	0.00125	0.00132	CcSEcCtD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PYY—Alzheimer's disease	0.00123	0.0313	CbGpPWpGaD
Nafarelin—Nausea—Rivastigmine—Alzheimer's disease	0.00122	0.00129	CcSEcCtD
Nafarelin—GNRHR—Peptide GPCRs—CCR5—Alzheimer's disease	0.00119	0.0303	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR6—Alzheimer's disease	0.00102	0.0261	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—CCR5—Alzheimer's disease	0.00101	0.0257	CbGpPWpGaD
Nafarelin—GNRHR—GPCRs, Other—HTR2A—Alzheimer's disease	0.000987	0.0252	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—PYY—Alzheimer's disease	0.000934	0.0238	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—NPS—Alzheimer's disease	0.000922	0.0235	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—APP—Alzheimer's disease	0.000857	0.0219	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GAL—Alzheimer's disease	0.00085	0.0217	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—Alzheimer's disease	0.000825	0.021	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—PLCB1—Alzheimer's disease	0.000809	0.0206	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR6—Alzheimer's disease	0.000779	0.0199	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—APP—Alzheimer's disease	0.000767	0.0195	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—PLCB1—Alzheimer's disease	0.000723	0.0184	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPY—Alzheimer's disease	0.000668	0.017	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—GAL—Alzheimer's disease	0.000647	0.0165	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—NPS—Alzheimer's disease	0.000611	0.0156	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—SST—Alzheimer's disease	0.000583	0.0149	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—APP—Alzheimer's disease	0.000568	0.0145	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—HTR2A—Alzheimer's disease	0.000555	0.0141	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PYY—Alzheimer's disease	0.000528	0.0135	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—NPY—Alzheimer's disease	0.000508	0.013	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—IAPP—Alzheimer's disease	0.000505	0.0129	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Alzheimer's disease	0.000496	0.0126	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CRH—Alzheimer's disease	0.000491	0.0125	CbGpPWpGaD
Nafarelin—GNRHR—G alpha (q) signalling events—F2—Alzheimer's disease	0.000486	0.0124	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PYY—Alzheimer's disease	0.000479	0.0122	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—NPS—Alzheimer's disease	0.000465	0.0119	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—SST—Alzheimer's disease	0.000444	0.0113	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR6—Alzheimer's disease	0.00044	0.0112	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—F2—Alzheimer's disease	0.000435	0.0111	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—APP—Alzheimer's disease	0.000432	0.011	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CDK5—Alzheimer's disease	0.000416	0.0106	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR6—Alzheimer's disease	0.0004	0.0102	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—CREB1—Alzheimer's disease	0.000396	0.0101	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—Alzheimer's disease	0.000375	0.00957	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Alzheimer's disease	0.000367	0.00937	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GAL—Alzheimer's disease	0.000366	0.00933	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GAL—Alzheimer's disease	0.000332	0.00847	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TTR—Alzheimer's disease	0.000324	0.00826	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—F2—Alzheimer's disease	0.000322	0.00821	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPY—Alzheimer's disease	0.000287	0.00733	CbGpPWpGaD
Nafarelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL2—Alzheimer's disease	0.000287	0.00732	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCR5—Alzheimer's disease	0.000286	0.00729	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—IAPP—Alzheimer's disease	0.000286	0.00728	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PYY—Alzheimer's disease	0.000283	0.00722	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—HTR2A—Alzheimer's disease	0.00028	0.00713	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CRH—Alzheimer's disease	0.000277	0.00707	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—NPS—Alzheimer's disease	0.000263	0.0067	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPY—Alzheimer's disease	0.000261	0.00665	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IAPP—Alzheimer's disease	0.000259	0.00661	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CRH—Alzheimer's disease	0.000252	0.00642	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—SST—Alzheimer's disease	0.000251	0.00639	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000251	0.00639	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CDK5—Alzheimer's disease	0.000245	0.00626	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—F2—Alzheimer's disease	0.000245	0.00625	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—APP—Alzheimer's disease	0.000244	0.00623	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—NPS—Alzheimer's disease	0.000239	0.00608	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000237	0.00605	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR6—Alzheimer's disease	0.000236	0.00602	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000231	0.00588	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—GAB2—Alzheimer's disease	0.000228	0.0058	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—SST—Alzheimer's disease	0.000228	0.0058	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—APP—Alzheimer's disease	0.000222	0.00566	CbGpPWpGaD
Nafarelin—GNRHR—GPCR ligand binding—CCL2—Alzheimer's disease	0.000219	0.00557	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PSENEN—Alzheimer's disease	0.000215	0.00547	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APH1A—Alzheimer's disease	0.000212	0.00539	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000209	0.00534	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NCSTN—Alzheimer's disease	0.000206	0.00525	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LRP1—Alzheimer's disease	0.000201	0.00512	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GAL—Alzheimer's disease	0.000196	0.005	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GFAP—Alzheimer's disease	0.000196	0.005	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—A2M—Alzheimer's disease	0.000173	0.00441	CbGpPWpGaD
Nafarelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Alzheimer's disease	0.000172	0.00439	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.00017	0.00435	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PSEN2—Alzheimer's disease	0.000167	0.00427	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—CCR5—Alzheimer's disease	0.000162	0.00412	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—HTR2A—Alzheimer's disease	0.000158	0.00403	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—PRKCG—Alzheimer's disease	0.000155	0.00395	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPY—Alzheimer's disease	0.000154	0.00393	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IAPP—Alzheimer's disease	0.000153	0.00391	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CRH—Alzheimer's disease	0.000149	0.00379	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCR5—Alzheimer's disease	0.000147	0.00374	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000144	0.00366	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NPS—Alzheimer's disease	0.000141	0.00359	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00014	0.00358	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—F2—Alzheimer's disease	0.000139	0.00353	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PTK2B—Alzheimer's disease	0.000138	0.00352	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—SST—Alzheimer's disease	0.000134	0.00343	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NTRK2—Alzheimer's disease	0.000134	0.00343	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GAB2—Alzheimer's disease	0.000134	0.00343	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CALM1—Alzheimer's disease	0.000134	0.00341	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GSK3A—Alzheimer's disease	0.000133	0.0034	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APP—Alzheimer's disease	0.000131	0.00334	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—F2—Alzheimer's disease	0.000126	0.00321	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PLCB1—Alzheimer's disease	0.000124	0.00315	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NGFR—Alzheimer's disease	0.000115	0.00294	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CREB1—Alzheimer's disease	0.000115	0.00292	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ADAM10—Alzheimer's disease	0.000113	0.00287	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—CCL2—Alzheimer's disease	0.000112	0.00286	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—S100B—Alzheimer's disease	0.000107	0.00272	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF2—Alzheimer's disease	0.000101	0.00259	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1R—Alzheimer's disease	9.81e-05	0.0025	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LPL—Alzheimer's disease	9.41e-05	0.0024	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MEF2C—Alzheimer's disease	9.32e-05	0.00238	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—PRKCG—Alzheimer's disease	9.15e-05	0.00233	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NGF—Alzheimer's disease	8.91e-05	0.00227	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCR5—Alzheimer's disease	8.67e-05	0.00221	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—HTR2A—Alzheimer's disease	8.48e-05	0.00216	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CALM1—Alzheimer's disease	7.91e-05	0.00202	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—APOE—Alzheimer's disease	7.88e-05	0.00201	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—LEP—Alzheimer's disease	7.88e-05	0.00201	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CAV1—Alzheimer's disease	7.81e-05	0.00199	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—ESR1—Alzheimer's disease	7.53e-05	0.00192	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—F2—Alzheimer's disease	7.44e-05	0.0019	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOTCH1—Alzheimer's disease	7.28e-05	0.00185	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—GSK3B—Alzheimer's disease	6.83e-05	0.00174	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CREB1—Alzheimer's disease	6.77e-05	0.00173	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—INS—Alzheimer's disease	6.74e-05	0.00172	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CCL2—Alzheimer's disease	6.63e-05	0.00169	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IGF1—Alzheimer's disease	6.52e-05	0.00166	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—NOS3—Alzheimer's disease	5.91e-05	0.00151	CbGpPWpGaD
Nafarelin—GNRHR—GPCR downstream signaling—AKT1—Alzheimer's disease	5.06e-05	0.00129	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—CASP3—Alzheimer's disease	5.02e-05	0.00128	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—IL6—Alzheimer's disease	4.98e-05	0.00127	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—MAPK8—Alzheimer's disease	4.61e-05	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—Signaling by GPCR—AKT1—Alzheimer's disease	4.6e-05	0.00117	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—VEGFA—Alzheimer's disease	4.26e-05	0.00108	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TGFB1—Alzheimer's disease	3.91e-05	0.000996	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—TP53—Alzheimer's disease	3.22e-05	0.00082	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—IL6—Alzheimer's disease	2.94e-05	0.00075	CbGpPWpGaD
Nafarelin—GNRHR—Signaling Pathways—AKT1—Alzheimer's disease	2.72e-05	0.000692	CbGpPWpGaD
